Extraction and Radiochemical Labeling of Licorice Root Extract and Investigation of Its Bioaffinity Using In Vitro Methods

Abstract

In recent years, increasing attention has been directed toward plant-derived extracts as potential agents for diagnostic and therapeutic applications in nuclear medicine. Breast cancer remains one of the most frequently diagnosed malignancies among women, highlighting the need for novel molecular imaging approaches. In this context, technetium-99m (^99mTc), a cornerstone radionuclide for single-photon emission computed tomography (SPECT), offers favorable physical characteristics for diagnostic imaging. This study aimed to extract and chemically characterize licorice root extract (LRE) and to investigate its in vitro bioactivity on breast cancer cell lines following labeling with ^99mTc. Chemical characterization of LRE was performed using high-performance liquid chromatography (HPLC), thin-layer chromatography (TLC), and liquid chromatography–quadrupole time-of-flight mass spectrometry (LC–QTOF–MS). Radiolabeling of LRE with ^99mTc was achieved using the stannous chloride reduction method, and the resulting radiochemically labeled compound ([^99mTc]LRE) was evaluated for radiochemical purity by thin-layer radiochromatography (TLRC). The in vitro bioactivity of [^99mTc]LRE was assessed using MCF-7 and MDA-MB-231 breast cancer cell lines. The radiolabeling procedure yielded [^99mTc]LRE with a radiochemical yield of 98.91 ± 1.27% (n = 4). These findings indicate that [^99mTc]LRE is a stable radiolabeled compound and suggest its potential applicability as a novel plant-based radiotracer for SPECT imaging in breast cancer research.

Keywords

• Breast cancer
• Licorice root
• MCF-7 and MDA-MB-231 cell line
• Technetium-99m (99mTc)

Supporting Institution

This study did not receive any financial support from any public, commercial, or non-profit funding agency.

Project Number

No project number is available for this study.

Ethical Statement

Ethical approval was not required for this study as it involved in vitro cell culture experiments only.

Thanks

The authors declare that there are no acknowledgements.

References

1. [1]. García-Aranda, M, Redondo, M. 2019. Immunotherapy: a challenge of breast cancer treatment. Cancers; 11(12): 1–19.
2. [2]. Sun, YS, Zhao, Z, Yang, ZN, et al. 2017. Risk factors and preventions of breast cancer. International Journal of Biological Sciences; 13(11): 1387–1397.
3. [3]. Bray, F, Laversanne, M, Sung, H, et al. 2024. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians; 74(3): 229–263.
4. [4]. Barba, D, León-Sosa, A, Lugo, P, et al. 2021. Breast cancer, screening and diagnostic tools: all you need to know. Critical Reviews in Oncology/Hematology; 157: 103174.
5. [5]. Jafari, SH, Saadatpour, Z, Salmaninejad, A, et al. 2018. Breast cancer diagnosis: imaging techniques and biochemical markers. Journal of Cellular Physiology; 233(7): 5200–5213.
6. [6]. Milosevic, M, Jankovic, D, Milenkovic, A, Stojanov, D. 2018. Early diagnosis and detection of breast cancer. Technology and Health Care; 26(4): 729–759.
7. [7]. Wang, L. 2017. Early diagnosis of breast cancer. Sensors (Basel); 17(7): 1572.
8. [8]. Duatti A. 2021. Review on 99mTc radiopharmaceuticals with emphasis on new advancements. Nuclear Medicine and Biology.; 92:202–216.

9. [9]. Spanu A, Chessa F, Cottu P, et al. 2002. The usefulness of 99mTc-tetrofosmin SPECT scintimammography in detecting small size primary breast carcinomas. International Journal of Oncology.; 21(4):831–840.
10. [10]. Taillefer R. 1999. The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Seminars in Nuclear Medicine.; 29(1):16–40.
11. [11]. Wang, ZY, Nixon, DW. 2016. Licorice and cancer. Nutrition and Cancer; 39(1): 1–5.
12. [12]. Murray, MT. 2020. Glycyrrhiza glabra (Licorice). In: Textbook of Natural Medicine, 5th edn.; Elsevier: Amsterdam, Netherlands, pp 85–90.
13. [13]. Kwon, YJ, Son, DH, Chung, TH, Lee, YJ. 2020. A review of the pharmacological efficacy and safety of licorice root from corroborative clinical trial findings. Journal of Medicinal Food; 23(1): 12–20.
14. [14]. Sharma, V, Katiyar, A, Agrawal, RC. 2018. Glycyrrhiza glabra: chemistry and pharmacological activity. In: Reference Series in Phytochemistry; Springer: Berlin, Germany, pp 87–100.
15. [15]. Vlaisavljević, S, Šibul, F, Sinka, I, et al. 2018. Chemical composition, antioxidant and anticancer activity of licorice from Fruska Gora locality. Industrial Crops and Products; 112: 217–224.
16. [16]. Teksöz, S, Biber Müftüler, FZ. 2019. Radioisotopes and biomedical applications in nuclear medicine. Nuclear Medicine Seminars; 5(1): 10–14.
17. [17]. Biber Müftüler, FZ, Yurt Kilcar, A, Unak, P. 2015. A perspective on plant origin radiolabeled compounds, their biological affinities and interaction between plant extracts with radiopharmaceuticals. Journal of Radioanalytical and Nuclear Chemistry; 306(1): 1–9.
18. [18]. Lewis, JS, Windhorst, AD, Zeglis, BM. 2019. Radiopharmaceutical Chemistry; Springer: Berlin, Germany.
19. [19]. Saha, GB. 2018. Radiopharmaceuticals and general methods of radiolabeling. In: Fundamentals of Nuclear Pharmacy; Springer: Berlin, Germany, pp 93–121.
20. [20]. Boschi, A, Uccelli, L, Martini, P. 2019. A picture of modern Tc-99m radiopharmaceuticals: production, chemistry, and applications in molecular imaging. Applied Sciences (Basel); 9(12): 2526.
21. [21]. Cheng, M, Zhang, J, Yang, L, et al. 2021. Recent advances in chemical analysis of licorice (Gan-Cao). Fitoterapia; 149: 104803.
22. [22]. Jiang, Y, Lu, HT, Chen, F. 2004. Preparative purification of glycyrrhizin extracted from the root of liquorice using high-speed counter-current chromatography. Journal of Chromatography A; 1033(1): 183–186.
23. [23]. Simons, R, Vincken, JP, Mol, LAM, et al. 2011. Agonistic and antagonistic estrogens in licorice root (Glycyrrhiza glabra). Analytical and Bioanalytical Chemistry; 401(1): 305–313.
24. [24]. Tian, M, Yan, H, Row, KH. 2008. Extraction of glycyrrhizic acid and glabridin from licorice. International Journal of Molecular Sciences; 9(4): 571–577.
25. [25]. Qiao, X, Song, W, Ji, S, et al. 2015. Separation and characterization of phenolic compounds and triterpenoid saponins in licorice (Glycyrrhiza uralensis) using comprehensive two-dimensional liquid chromatography. Journal of Chromatography A; 1402: 36–45.
26. [26]. Moghadam, ER, Ang, HL, Asnaf, SE, et al. 2020. Broad-spectrum preclinical antitumor activity of chrysin: current trends and future perspectives. Biomolecules; 10(10): 1374.
27. [27]. Rahayu, I. 2022. Study of Moringa oleifera leaf infusion: in vitro and in vivo biological activities. Molecules; 27: 4017.
28. [28]. Sheela, ML, Ramakrishna, MK, Salimath, BP. 2006. Angiogenic and proliferative effects of VEGF in Ehrlich ascites tumor cells inhibited by Glycyrrhiza glabra. International Immunopharmacology; 6(3): 494–498.
29. [29]. Ahmad, R., Alqathama, A., Aldholmi, M., et al. 2023. Biological screening of Glycyrrhiza glabra L. for antidiabetic and anticancer activity. Pharmaceuticals.;16(1):1-13.